Literature DB >> 18365755

Bladder cancer, GSTs, NAT1, NAT2, SULT1A1, XRCC1, XRCC3, XPD genetic polymorphisms and coffee consumption: a case-control study.

Loredana Covolo1, Donatella Placidi, Umberto Gelatti, Angela Carta, Antonio Scotto Di Carlo, Paolo Lodetti, Antonio Piccichè, Grazia Orizio, Marcello Campagna, Cecilia Arici, Stefano Porru.   

Abstract

The aim of the study was to investigate NAT1, NAT2, GSTM1, GSTT1, GSTP1, SULT1A1, XRCC1, XRCC3 and XPD genetic polymorphisms, coffee consumption and risk of bladder cancer (BC) through a hospital-based case-control study. The study population included 197 incident BC cases and 211 controls. The association between genetic polymorphisms, coffee drinking and BC risk was assessed by logistic regression taking into account age, education, tobacco smoking and occupational exposures to polycyclic aromatic hydrocarbons and aromatic amines. No association was found between the genetic polymorphisms investigated and BC risk according to coffee consumption apart of a significant increased BC risk among GSTP1 105-114 Val carriers heavy coffee drinkers (>3 cups/day) (OR 3.18, 95% CI 1.06-9.55). In conclusion our findings suggest a very limited role, if any, of genetic polymorphisms investigated in modulating the BC risk in coffee drinkers.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18365755     DOI： 10.1007/s10654-008-9238-2

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


  41 in total

Review 1.  Polymorphisms in DNA repair genes and associations with cancer risk.

Authors:  Ellen L Goode; Cornelia M Ulrich; John D Potter
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2002-12       Impact factor: 4.254

2.  Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer.

Authors:  Rayjean J Hung; Paul Brennan; Christian Malaveille; Stefano Porru; Francesco Donato; Paolo Boffetta; John S Witte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-06       Impact factor: 4.254

3.  Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk?

Authors:  Cristiane Murta-Nascimento; Debra T Silverman; Manolis Kogevinas; Montserrat García-Closas; Nathaniel Rothman; Adonina Tardón; Reina García-Closas; Consol Serra; Alfredo Carrato; Cristina Villanueva; Mustafa Dosemeci; Francisco X Real; Núria Malats
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

4.  Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer.

Authors:  Daya Shankar Lal Srivastava; Dhruva Kumar Mishra; Anil Mandhani; Balraj Mittal; Anant Kumar; Rama Devi Mittal
Journal:  Eur Urol       Date:  2005-03-07       Impact factor: 20.096

5.  Total and specific fluid consumption as determinants of bladder cancer risk.

Authors:  Cristina M Villanueva; Kenneth P Cantor; Will D King; Jouni J K Jaakkola; Sylvaine Cordier; Charles F Lynch; Stefano Porru; Manolis Kogevinas
Journal:  Int J Cancer       Date:  2006-04-15       Impact factor: 7.396

6.  Are coffee and tea consumption associated with urinary tract cancer risk? A systematic review and meta-analysis.

Authors:  M P Zeegers; F E Tan; R A Goldbohm; P A van den Brandt
Journal:  Int J Epidemiol       Date:  2001-04       Impact factor: 7.196

7.  Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2).

Authors:  B J Majer; E Hofer; C Cavin; E Lhoste; M Uhl; H R Glatt; W Meinl; S Knasmüller
Journal:  Food Chem Toxicol       Date:  2005-03       Impact factor: 6.023

8.  Fluid consumption and the risk of bladder cancer: results of a multicenter case-control study.

Authors:  B Geoffroy-Perez; S Cordier
Journal:  Int J Cancer       Date:  2001-09       Impact factor: 7.396

9.  Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.

Authors:  Rayjean J Hung; Paolo Boffetta; Paul Brennan; Christian Malaveille; Umberto Gelatti; Donatella Placidi; Angela Carta; Agnès Hautefeuille; Stefano Porru
Journal:  Carcinogenesis       Date:  2004-01-16       Impact factor: 4.944

10.  GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.

Authors:  Rayjean J Hung; Paolo Boffetta; Paul Brennan; Christian Malaveille; Agnès Hautefeuille; Francesco Donato; Umberto Gelatti; Massimiliano Spaliviero; Donatella Placidi; Angela Carta; Antonio Scotto di Carlo; Stefano Porru
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396
View more
  24 in total

1.  Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis.

Authors:  Yuanyi Wu; Yong Yang
Journal:  Tumour Biol       Date:  2014-02-07

2.  Association between the SULT1A1 Arg213His polymorphism and the risk of bladder cancer: a meta-analysis.

Authors:  Chih-Ming Su; Mei-Chieh Chen; I-Chan Lin; Hsin-An Chen; Ming-Te Huang; Chih-Hsiung Wu; Kun-Hung Shen; Yuan-Hung Wang
Journal:  Tumour Biol       Date:  2014-04-25

3.  Susceptibility of XPD and RAD51 genetic variants to carcinoma of urinary bladder in North Indian population.

Authors:  Ranbir Chander Sobti; Saranjeet Kaur; Vijay Lakshmi Sharma; Shrawan Kumar Singh; Seyed Ali Hosseini; Rupinder Kler
Journal:  DNA Cell Biol       Date:  2011-07-08       Impact factor: 3.311

4.  Genetic polymorphisms of glutathione S-transferase M1 and bladder cancer risk: a meta-analysis of 26 studies.

Authors:  RongGui Zhang; GuangYong Xu; WenJun Chen; WeiLi Zhang
Journal:  Mol Biol Rep       Date:  2010-11-17       Impact factor: 2.316

5.  CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer.

Authors:  Sofia Pavanello; Giuseppe Mastrangelo; Donatella Placidi; Marcello Campagna; Alessandra Pulliero; Angela Carta; Cecilia Arici; Stefano Porru
Journal:  Eur J Epidemiol       Date:  2010-06-18       Impact factor: 8.082

6.  Polymorphisms in DNA repair genes, smoking, and bladder cancer risk: findings from the international consortium of bladder cancer.

Authors:  Mariana C Stern; Jie Lin; Jonine D Figueroa; Karl T Kelsey; Anne E Kiltie; Jian-Min Yuan; Giuseppe Matullo; Tony Fletcher; Simone Benhamou; Jack A Taylor; Donatella Placidi; Zuo-Feng Zhang; Gunnar Steineck; Nathaniel Rothman; Manolis Kogevinas; Debra Silverman; Nuria Malats; Stephen Chanock; Xifeng Wu; Margaret R Karagas; Angeline S Andrew; Heather H Nelson; D Timothy Bishop; Sei Chung Sak; Ananya Choudhury; Jennifer H Barrett; Faye Elliot; Román Corral; Amit D Joshi; Manuela Gago-Dominguez; Victoria K Cortessis; Yong-Bing Xiang; Yu-Tang Gao; Paolo Vineis; Carlotta Sacerdote; Simonetta Guarrera; Silvia Polidoro; Alessandra Allione; Eugen Gurzau; Kvetoslava Koppova; Rajiv Kumar; Peter Rudnai; Stefano Porru; Angela Carta; Marcello Campagna; Cecilia Arici; Sung Shim Lani Park; Montserrat Garcia-Closas
Journal:  Cancer Res       Date:  2009-08-25       Impact factor: 12.701

7.  Coffee consumption, genetic susceptibility and bladder cancer risk.

Authors:  Cristina M Villanueva; Debra T Silverman; Cristiane Murta-Nascimento; Núria Malats; Montserrat Garcia-Closas; Francesc Castro; Adonina Tardon; Reina Garcia-Closas; Consol Serra; Alfredo Carrato; Nathaniel Rothman; Francisco X Real; Mustafa Dosemeci; Manolis Kogevinas
Journal:  Cancer Causes Control       Date:  2008-09-17       Impact factor: 2.506

8.  NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.

Authors:  Kunyi Zhang; Lijuan Gao; Yuqi Wu; Jianyi Chen; Chengguang Lin; Shaohua Liang; Jianxin Su; Jinming Ye; Xuyu He
Journal:  Int J Clin Exp Med       Date:  2015-06-15

9.  DNA repair gene XRCC3 polymorphisms and bladder cancer risk: a meta-analysis.

Authors:  Qiliu Peng; Cuiju Mo; Weizhong Tang; Zhiping Chen; Ruolin Li; Limin Zhai; Shi Yang; Junrong Wu; Jingzhe Sui; Shan Li; Xue Qin
Journal:  Tumour Biol       Date:  2013-10-09

10.  Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.

Authors:  Su-Xia Li; Qiang-Sheng Dai; Su-Xiu Chen; Shao-Dan Zhang; Xiao-Yu Liao; Xia Deng; Hong-Bo Chi; Feng-Jie Li; Jin-Hong Zhu; Yi-Yan Jiang
Journal:  Tumour Biol       Date:  2013-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.